Valuation check: TMO's profit margin is 15.06%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Thermo Fisher Scientific's profit margin stands at 15.06% as of June 2026. That compares with 15.24% in the prior-year period — down 1.2% year over year. That is below the Healthcare sector average of 15.58%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Thermo Fisher Scientific reported 15.06% in profit margin versus 15.24% a year earlier — a 1.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Thermo Fisher Scientific sits lower the Healthcare benchmark (15.58%) with a profit margin of 15.06%. That is roughly 3.4% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of 15.06% for Thermo Fisher Scientific means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Thermo Fisher Scientific's profit margin evolved across reporting periods, while the comparison chart places TMO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.